Cetera Investment Advisers
UTHR icon

Cetera Investment Advisers’s United Therapeutics UTHR Stock Holding History

Cetera Investment Advisers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.85M Buy
8,944
+296
+3% +$167K ﹤0.01% 1646
2026
Q1 		$5.13M Buy
8,648
+338
+4% +$168K 0.01% 1484
2025
Q4 		$4.05M Buy
8,310
+1,343
+19% +$625K ﹤0.01% 1609
2025
Q3 		$2.92M Sell
6,967
-960
-12% -$323K ﹤0.01% 1849
2025
Q2 		$2.28M Sell
7,927
-97
-1% -$29K ﹤0.01% 1749
2025
Q1 		$2.47M Sell
8,024
-691
-8% -$237K ﹤0.01% 1593
2024
Q4 		$3.08M Buy
8,715
+463
+6% +$170K 0.01% 1342
2024
Q3 		$2.96M Buy
8,252
+2,085
+34% +$704K 0.01% 1335
2024
Q2 		$1.96M Buy
6,167
+493
+9% +$130K ﹤0.01% 1589
2024
Q1 		$1.3M Buy
5,674
+3,015
+113% +$680K ﹤0.01% 1870
2023
Q4 		$585K Buy
2,659
+197
+8% +$45.4K ﹤0.01% 1408
2023
Q3 		$556K Buy
2,462
+210
+9% +$48.4K ﹤0.01% 1363
2023
Q2 		$497K Buy
2,252
+295
+15% +$65.3K ﹤0.01% 1454
2023
Q1 		$438K Buy
1,957
+6
+0.3% +$1.48K ﹤0.01% 1505
2022
Q4 		$543K Buy
1,951
+792
+68% +$200K 0.01% 1328
2022
Q3 		$243K Buy
1,159
+203
+21% +$45.4K ﹤0.01% 1403
2022
Q2 		$225K Buy
+956
New +$194K ﹤0.01% 1604

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cetera Investment Advisers's UTHR Position: Q2 2026 in Review

Cetera Investment Advisers increased its United Therapeutics (UTHR) stake by 3.4% in Q2 2026, buying an estimated $167K and bringing the position to 8,944 shares worth $4.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1646.

Cetera Investment Advisers first reported a position in UTHR in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.13M in Q1 2026. 883 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cetera Investment Advisers held 8,944 shares of United Therapeutics worth $4.85M as of Q2 2026.
  • Cetera Investment Advisers bought 296 United Therapeutics shares in Q2 2026, an estimated $167K.
  • United Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1646 holding.
  • Cetera Investment Advisers first reported a position in United Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Cetera Investment Advisers's United Therapeutics position peaked at $5.13M in Q1 2026.
  • 883 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.